# Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department

> **NCT00559338** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 104 (actual)

## Conditions studied

- Heart Failure, Congestive
- Cardiomyopathy

## Interventions

- **DRUG:** recombinant B-type, natriuretic peptide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00559338
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2007-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00559338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00559338, "Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00559338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*